The FDA, under Commissioner Makary, plans to deploy AI-assisted scientific review processes across its centers by June 30, 2025, raising legal questions about data security, the influence of AI on review outcomes, and the potential for new judicial challenges.
View full story…
FDA Implements AI-Assisted Review Processes for Premarket Applications by 2025
